Events

International Sepsis Forum 2017

International Sepsis Forum 2017 11-13 September, 2017 Paris, France Dr Leo McHugh presented an algorithmic method for interpreting the performance of high accuracy diagnostics when judged against clinical diagnoses known to contain uncertainty. This is the first public release of this method and associated open-course software for the diagnostics community. The method and software has…

Read more

European Molecular Diagnostics 2017

Molecular Diagnostics Europe 10-13 April 2017 Lisbon, Portugal. Dayle Sampson, Director of Bioinformatics at Immunexpress, presented on the Dynamics of Host Response in Severe Respiratory Illness. He described ongoing work at Immunexpress on using different signatures to understand the contribution of different pathogen classes to sepsis.

Read more

International Sepsis Forum 2016

International Sepsis Forum 2016 December 6-8, 2016 Paris, France. Marc Bonten, founder of the MARS sepsis consortium presented SeptiCyte™ LAB data and by Thierry Calandra, author of the international Surviving Sepsis campaign also discussed the utility of SeptiCyte™ in ICU management. Independent investigators from the Utrecht Medical Centre presented data from two investigator lead trials…

Read more

FDA public hearing: Microbiology Medical Devices Panel for Sepsis

FDA public hearing: Microbiology Medical Devices Panel for Sepsis November 10, 2016 Washington, DC. This was an open hearing on how recent regulatory changes affect the application of host response sepsis diagnostics for the clinical management of Antibiotics. Attended by the FDA Molecular Diagnostics Advisory Board IXP Staff in Attendance: Leo McHugh, Roy Davis

Read more

European Society for Intensive Care Medicine

European Society for Intensive Care Medicine October 1-5, 2016 Milan, Italy. Dr Mahdad Noursadeghi, of University College London presented preliminary results in a validation trial of an Immunexpress developed signature for the diagnosis of bacterial infection in patients presenting to ER, and for a second signature in the same validation cohort for differentiating bacterial from…

Read more

National Sepsis Forum 2016

National Sepsis Forum 2016 September 12, 2016 New York, NY. CEO Roz Brandon invited to attend the 3rd National Sepsis Forum 2016 held by the Rory Staunton Foundation, “New Ideas on Sepsis.” New York State has led the country in its holistic approach to sepsis prevention, treatment and awareness. The Third National Forum will showcase the advances made by New…

Read more

American Thoracic Society 2016

American Thoracic Society 2016 May 13-18, 2016 San Francisco, CA. Bert Lopansri of Intermountain Health Care presented data on the usage of SeptiCyte™ technology to better inform management and reduce risk for patients in the early stages of ICU admission when other diagnostics available at this time either lack accuracy or are not available.

Read more

36th International Symposium on Intensive Care and Emergency Medicine

36th International Symposium on Intensive Care and Emergency Medicine March 15-18, 2016 Brussels, Belgium. Russ Miller, of Intermountain Healthcare presented data on the market need for accurate sepsis diagnostics using results from the IXP VENUS trial showing that expert physicians agree on a diagnosis of sepsis in between 60 to 80% of cases, highlighting the…

Read more

Personalized Medicine World Conference

Personalized Medicine World Conference January 24-27, 2016 Silicon Valley, CA. Invited talk by Leo McHugh on host response transcriptomics for the diagnosis and management on critical infections. Presented results of various SeptiCyte™ validation trials and in-silico analyses for other clinical management related gene expression signatures.

Read more

Previous Events